MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 116 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q4 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81,534,800 | -41.2% | 8,153,480 | -26.9% | 0.03% | -37.0% |
| Q2 2023 | $138,647,403 | -15.8% | 11,154,256 | -5.1% | 0.05% | -17.9% |
| Q1 2023 | $164,722,392 | -11.8% | 11,757,487 | -9.9% | 0.06% | -13.8% |
| Q4 2022 | $186,716,307 | -48.3% | 13,047,960 | -7.8% | 0.06% | -51.9% |
| Q3 2022 | $361,273,000 | +0.2% | 14,150,891 | +11.5% | 0.14% | +8.9% |
| Q2 2022 | $360,556,000 | +14.0% | 12,691,171 | +41.6% | 0.12% | +31.9% |
| Q1 2022 | $316,198,000 | -5.7% | 8,965,103 | +12.0% | 0.09% | +2.2% |
| Q4 2021 | $335,326,000 | +23.3% | 8,003,021 | +44.4% | 0.09% | +15.0% |
| Q3 2021 | $272,067,000 | +29.9% | 5,543,329 | +10.4% | 0.08% | +31.1% |
| Q2 2021 | $209,460,000 | +9.2% | 5,019,413 | -6.8% | 0.06% | +3.4% |
| Q1 2021 | $191,855,000 | +61.4% | 5,383,118 | +27.1% | 0.06% | +55.3% |
| Q4 2020 | $118,837,000 | – | 4,236,607 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $216,810,330 | 13.15% |
| 12 West Capital Management LP | 6,463,111 | $64,631,110 | 5.85% |
| Alpine Peaks Capital, LP | 359,300 | $3,593,000 | 2.50% |
| Connacht Asset Management LP | 24,155 | $241,550 | 1.43% |
| QVIDTVM Management LLC | 163,230 | $1,632,300 | 1.27% |
| BRAIDWELL LP | 3,974,857 | $39,748,570 | 1.26% |
| Mesirow Institutional Investment Management, Inc. | 926,277 | $9,262,770 | 0.94% |
| Granite Investment Partners, LLC | 1,488,359 | $14,883,590 | 0.62% |
| CARLSON CAPITAL L P | 635,000 | $6,350,000 | 0.50% |
| Pier Capital, LLC | 290,563 | $2,905,630 | 0.47% |